![RFI Logo - Full Banner - Black on White [985x141].png](https://static.wixstatic.com/media/bb044f_d483cd968c374fc0a05dae2ac622f27f~mv2.png/v1/fill/w_454,h_65,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/RFI%20Logo%20-%20Full%20Banner%20-%20Black%20on%20White%20%5B985x141%5D.png)
This study analyses China's infrastructual preparedness to deliver emerging treatments to combat Alzheimer's disease using desk research, expert interviews, and a simulation model.
A combination of desk research and expert interviews was used to understand the existing obstacles that would limit access to and identify potential challenges to care delivery that might improve timely access to a disease-modifying Alzheimer’s treatment in China.
Findings from the study suggest that China’s healthcare system is ill-prepared to provide timely access to Alzheimer’s treatment. The current pathway, in which patients seek evaluation in hospital-based memory clinics without a prior assessment in primary care, would overwhelm existing capacity.
Closing this gap would require the introduction of high-performing blood tests, greater reliance on cerebrospinal fluid (CSF) testing, and expansion on positron emission tomography (PET) capacity.
This report was jointly co-authored by a team from RFI (Joanne Yoong, Oliver Yuan, Loh Wei Kok) and the University of Southern California’s Center for Improving Chronic Illness Care (Soeren Mattke).
Read the full study at https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.13348